Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Salvatore Nurra"'
Altering redox homeostasis provides distinctive therapeutic opportunities for the treatment of pancreatic cancer. Quinazolinediones (QDs) are novel redox modulators that we previously showed to induce potent growth inhibition in pancreatic ductal ade
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b56d84210eaa9020a1d26280f34dea7
https://europepmc.org/articles/PMC6688507/
https://europepmc.org/articles/PMC6688507/
Autor:
Giuseppe Lubinu, Nicolino Pala, Alberto Mariani, Pierluigi Madau, Vanna Sanna, Salvatore Nurra, Mario Sechi
Publikováno v:
Journal of Agricultural and Food Chemistry. 63:2026-2032
With the aim to obtain controlled release and to preserve the antioxidant activity of the polyphenols, nanoencapsulation of white tea extract into polymeric nanoparticles (NPs) based on poly(ε-caprolactone) (PCL) and alginate was successfully perfor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e2da0bf130d7c30fb5a52d10b97b017
https://doi.org/10.1021/jf505850q
https://doi.org/10.1021/jf505850q
Autor:
Baek Kim, Nicolino Pala, Salvatore Nurra, Dominga Rogolino, Robert A. Domaoal, Mario Sechi, Annelies Stevaert, Salvatore A. E. Marras, Lieve Naesens, Mauro Carcelli, Mercedes Alfonso-Prieto, Caitlin Shepard
Publikováno v:
Molecular Pharmacology. 87:323-337
The influenza virus PA endonuclease, which cleaves capped cellular pre-mRNAs to prime viral mRNA synthesis, is a promising target for novel anti-influenza virus therapeutics. The catalytic center of this enzyme resides in the N-terminal part of PA (P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c633e5c9edd9151abba5075ec11b68ae
https://doi.org/10.1124/mol.114.095588
https://doi.org/10.1124/mol.114.095588
Autor:
Nicolino Pala, Mario Sechi, Salvatore Nurra, Salvatore Marceddu, Vanna Sanna, Divya Pathania, Nouri Neamati
Publikováno v:
Journal of medicinal chemistry (Online) 59 (2016): 5209–5220. doi:10.1021/acs.jmedchem.5b01571
info:cnr-pdr/source/autori:Sanna V.; Nurra S.; Pala N.; Marceddu S.; Pathania D.; Neamati N.; Sechi M./titolo:Targeted Nanoparticles for the Delivery of Novel Bioactive Molecules to Pancreatic Cancer Cells/doi:10.1021%2Facs.jmedchem.5b01571/rivista:Journal of medicinal chemistry (Online)/anno:2016/pagina_da:5209/pagina_a:5220/intervallo_pagine:5209–5220/volume:59
info:cnr-pdr/source/autori:Sanna V.; Nurra S.; Pala N.; Marceddu S.; Pathania D.; Neamati N.; Sechi M./titolo:Targeted Nanoparticles for the Delivery of Novel Bioactive Molecules to Pancreatic Cancer Cells/doi:10.1021%2Facs.jmedchem.5b01571/rivista:Journal of medicinal chemistry (Online)/anno:2016/pagina_da:5209/pagina_a:5220/intervallo_pagine:5209–5220/volume:59
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with poor prognosis and limited therapeutic options. Therefore, there is an urgent need to identify new, safe, and targeted therapeutics for effective treatment of late as well as early
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a49316665ceac3b3192355f01ac6631c
http://www.cnr.it/prodotto/i/356048
http://www.cnr.it/prodotto/i/356048